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Abstract
Background: Wnt proteins are a family of secreted signaling molecules that regulate key developmental processes
in metazoans. The molecular basis of Wnt binding to Frizzled and LRP5/6 co-receptors has long been unknown due
to the lack of structural data on Wnt ligands. Only recently, the crystal structure of the Wnt8-Frizzled8-cysteine-rich-
domain (CRD) complex was solved, but the significance of interaction sites that influence Wnt signaling has not
been assessed.
Results: Here, we present an extensive structure-function analysis of mouse Wnt3a in vitro and in vivo. We
provide evidence for the essential role of serine 209, glycine 210 (site 1) and tryptophan 333 (site 2) in Fz
binding. Importantly, we discovered that valine 337 in the site 2 binding loop is critical for signaling without
contributing to binding. Mutations in the presumptive second CRD binding site (site 3) partly abolished Wnt
binding. Intriguingly, most site 3 mutations increased Wnt signaling, probably by inhibiting Wnt-CRD
oligomerization. In accordance, increasing amounts of soluble Frizzled8-CRD protein modulated Wnt3a
signaling in a biphasic manner.
Conclusions: We propose a concentration-dependent switch in Wnt-CRD complex formation from an inactive
aggregation state to an activated high mobility state as a possible modulatory mechanism in Wnt signaling
gradients.
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Background
Wnts are key mediators of developmental processes
throughout the metazoan kingdom [1-3]. Molecules of
the Wnt family are characterized by a conserved pattern
of 22 to 24 cysteines and a post-translational lipid modi-
fication at their N-terminal half [4]. Upon transport
through a specialized secretory route, they act as mor-
phogens in a variety of tissues by forming concentration
gradients in the extracellular space [5]. Wnt secretion is
dependent on the activity of Wntless/Evi, a conserved
transmembrane protein, which functions as a cargo
receptor for Wnt proteins in diverse phyla [6,7]. Secreted
Wnts activate canonical or non-canonical signaling path-
ways in responder cells by binding to seven-pass trans-
membrane receptors of the Frizzled (Fz) family and
respective co-receptors LRP5/6 and ROR. The N-terminal
cysteine-rich domain (CRD) of Fz receptors serves as the
binding domain for Wnt ligands and is shared by the
alternative Ror2 receptor and secreted Frizzled-related
proteins (sFRPs) [8]. The post-translational addition of
palmitate or palmitoic acid to Wnts renders them highly
hydrophobic and is believed to control their secretion and
membrane localization [4,9,10]. It is unknown, however,
how Wnt proteins are recruited from the membrane to
signaling complexes and how binding to Fz-CRD-related
proteins regulates their signaling range in the extracellular
space.
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Recently, Janda et al. [9] presented the crystal struc-
ture of the Xenopus Wnt8 in complex with mouse Fz8-
CRD. Wnt8 was shown to have a two-domain structure
in which the alpha-helical N-terminal domain (NTD)
formed a contact with Fz via the palmitoic acid lipid
group (site 1) whereas the conserved region in the
C-terminal domain (CTD) formed a strong hydrophobic
contact with a groove in the Fz8-CRD (site 2). Interest-
ingly, it was shown that a mini-Wnt comprising only the
CTD is able to bind to the Fz8-CRD autonomously [9].
Janda et al. have in addition reported a third contact site
in the crystal structure designated as pseudo site 3,
which was speculated to mediate asymmetric Wnt/Fz
dimerization and thus self-assembly to polymers. Never-
theless, whether and how site 1, 2, and 3 residues impact
on biological Wnt function under relevant physiological
conditions remained unknown.
Here, we present a mutational analysis of the mouse
Wnt3a-Fz8-CRD interaction on the basis of the Xenopus
Wnt8-Fz8-CRD crystal structure (Figure 1A). Our ana-
lysis defined the highly conserved hydrophobic Trp333
within site 2 to be critical for Fz binding while it re-
quired several adjacent residues to induce full signaling.
In particular, we identified Val337 as a residue essential
for signaling activity without contributing to receptor
binding. Mutations in pseudo site 3 either abolished or
enhanced Wnt3a signaling, suggesting a dual role in
signal modulation. Likewise, soluble Fz8-CRD protein
modulated Wnt signaling in a biphasic manner, prob-
ably through influencing the stoichiometry of membrane-
detached ligand-receptor complexes. In summary, our
study presents a systematic dissection of the Wnt3a-
Fz8-CRD complex and identifies sites competent for
binding and for signaling in vitro as well as in vivo,
providing a model for the modulation of Wnt activity
by CRD-related proteins.
Results
Mutational analysis of in vitro Wnt3a activity
To predict critical sites in mouse Wnt3a required for Fz
binding, we generated a structural model of the mouse
Wnt3a-Fz8-CRD complex adopting the recently published
X-ray structure (Figure 1A,E). As demonstrated by Janda
et al., the Wnt molecule contacts the Fz-CRD at two dis-
tinct binding sites within the NTD and CTD designated
as sites 1 and 2, respectively (Figure 1A). Interaction at
site 1 is dominated by the lipid group attached to Ser209
in Wnt3a (Figure 1B), while site 2 is located within a
Figure 1 Structural model for mouse Wnt3a-Fz8 interaction. (A) Overview of the mouse Wnt3a-Fz8-CRD complex. Wnt3a is in grey, Fz8-CRD
in blue. The binding sites (site 1, yellow; site 2, red; pseudo site 3, pink) are highlighted and the respective residues marked. Close-up views of
binding sites 1 (B) and 2 (C), and pseudo site 3 (D). (E) Alignment of Xenopus Wnt8 and mouse Wnt3a sequences. Mutations introduced into site
1 (yellow), site 2 (red) and site 3 (pink) are indicated.
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conserved hydrophobic loop (C329-V337) in the CTD
of Wnt3a (Figure 1C) [9]. The third site, designated
as pseudo site 3, constitutes a large interface between
Wnt3a and a second CRD (Figure 1D). To test experimen-
tally for the relevance of each of the sites that we pre-
dicted to be involved in CRD binding, we mutated each of
them to alanine. Glycine, valine or alanine residues were
substituted by arginine. Each Wnt3a mutant was first
tested for its biological activity using a Wnt reporter assay
(Figure 2). To exclude the possibility that the observed ac-
tivity loss resulted from impaired secretion of the mutant
Wnt3a proteins, we analyzed protein levels in the cell
supernatants and lysates of transfected human embryonic
kidney (HEK) 293T cells by Western blotting. As shown
in Figure 2B,D, the secretion levels of most mutant Wnt3a
proteins were comparable to that of the wild-type protein
levels, indicating that the mutations introduced did not
significantly alter protein secretion. Site 1 mutants, S209A
and G210R, are an exception, as here secretion is most
probably impaired by the lack of lipid modification (see
below). Moreover, W218A also showed reduced secretion,
which might be due to partial misfolding caused by the
substitution of the tryptophan residue. A quantitative ana-
lysis of the observed secretion levels revealed about 60%
Figure 2 Effect of Wnt3a point mutants on signaling activity. (A, C, E) Wnt3a point mutants from sites 1, 2 and 3 were tested in the Wnt
reporter assay for their activity and compared with wild-type Wnt3a. HEK293T cells were transiently transfected with luciferase-based TCF/Wnt
reporter with wild-type Wnt3a or the indicated mutant constructs. (B, D, F) Secretion levels of Wnt3a mutants analyzed by Western blot. HEK293T
cells were transfected with wild-type Wnt3a or the indicated mutant constructs. Supernatants and cell lysates were analyzed 48 hr after
transfection. Membranes were probed with Wnt3a and α-tubulin (loading control) antibodies. (G) Effect of double mutants on signaling
activity. (H) Secretion levels of Wnt3a double mutants in HEK293T cells. Experiments were carried out in triplicate. Error bars depict standard
deviation. Statistical significance in relative luciferase activity levels (A, C, E, G) of Wnt3a mutants compared with wild-type Wnt3a is indicated in the
following way: *P< 0.05, **P < 0.01, ***P < 0.001 and n.s. as not significant according to Student’s t-test.
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diminution for W218A and more than 90% for S209A and
G210R (Additional file 1: Figure S1).
We observed that Wnt3a mutations introduced into
site 1 reduced signaling activity only moderately, with
the exception of S209A and G210R, which caused a
dramatic loss in signaling activity (Figure 2A). When we
combined mutations K204A and L208A, which had only
a mild effect as individual mutants, the loss of signaling
activity of the double mutant was more pronounced, al-
though residual signaling was still detectable (Figure 2G).
Mutations in site 2 generally showed a more pronounced
effect on signaling activity. In particular, C335A and V337R
mutations resulted in a complete loss of the reporter gene
activation (Figure 2C). While F331A and W333A single
mutations still showed some residual activity, the signaling
level of the double mutant (F331A/W333A) was compar-
able to the control (vector only) (Figure 2G).
We then asked whether the predicted interaction
residues in site 3 were also involved in Wnt3a signaling.
As demonstrated in Figure 2E, site-directed mutations at
three positions, V60R, E68A and F169A, significantly de-
creased signaling activity in the Wnt reporter assay. The
E68A/F169A double mutant did not show any residual
activity (Figure 2G). However, in contrast to site 1 and
site 2 mutations, a majority of the mutations introduced
into site 3 augmented Wnt signaling compared to wild-
type levels, with A96R showing the most pronounced
effect. As with site 1 and 2 mutations, we further con-
firmed that all site 3 mutant proteins were detectable at
comparable levels in the cell supernatants (Figure 2F,
Additional file 1: Figure S1). Altogether, these data led
us to conclude that site 3 has a physiological relevance
in canonical Wnt signaling.
Impact of Wnt3a mutations on direct binding to Frizzled
To analyze whether the introduced Wnt3a mutations af-
fected Wnt-Fz binding efficiency, we performed pull-down
assays using a recombinant Fz8-CRD-Fc fusion protein. As
a negative control, the Fc protein alone was applied. Inter-
estingly, binding of site 2 mutant W333A to the Fz8-CRD-
Fc was nearly abolished compared to wild-type Wnt3a,
while the C335A mutation still had some residual bind-
ing activity (Figure 3A). More surprisingly, the F331A
and V337R mutations, although lacking signaling ac-
tivity, did not show significantly reduced Fz8-CRD bind-
ing. The double mutant F331/W333A was comparable
to the W333A single mutant in the pull-down assay
(Figure 3A). Site 1 mutants, S209A and G210R, showed
a complete loss of binding while the binding of site 1
double mutant K204A/L208A was not significantly re-
duced. Site 3 mutants, V60R and E68A, showed only min-
imal binding to Fz-CRD. F169A as well as the double
mutant E68A/F169A completely failed to bind in the pull-
down assay. Site 3 mutants that showed increased signal-
ing activity showed full binding as demonstrated for A96R
(Figure 3A). A similar result was obtained for S92A and
R173A (data not shown). In summary, our binding data
indicate that site 2 residues, F331 and V337, are crucial
for signaling without contributing essentially to Fz-CRD
binding. To evaluate whether the loss of binding and
signaling activity observed for S209A and G210R mu-
tants (site 1) might be due to a lack of hydrophobicity
Figure 3 Binding of Wnt3a mutants to Fz8-CRD-Fc. (A) Binding efficiency of mutants from sites 1, 2 and 3, and double mutants were
analyzed by precipitation from a conditioned medium with recombinant Fz8-CRD-Fc or Fc alone pre-bound to Protein G agarose beads. Bound
protein fractions were analyzed by immunoblotting using anti-Wnt3a antibody. (B) Pull-down assay of wild-types Wnt3a and site 1 mutants
S209A and G210R with Blue Sepharose beads. BS, Blue Sepharose;s IgG, immunoglobulin G; IP, immunoprecipitation; CM, Conditioned Medium.
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(lipidation), we precipitated equal amounts of wild-type
Wnt3a and the respective mutant proteins with Blue Seph-
arose (Figure 3B). While most of the wild-type Wnt3a was
bound by the Sepharose, both mutant Wnt3a proteins
were poorly retained in the Blue Sepharose precipitate,
indicating that G210R could be similarly impaired in
acylation as S209A.
Individual Wnt3a protein domains do not show
independent signaling activity
It was shown previously that a mini-Wnt comprising the
Xenopus Wnt8 CTD shows autonomous binding to Fz [9].
In addition, the inhibitory effects of Wnt NTDs have been
reported in various studies [11-15]. To examine whether
the mouse Wnt3a subdomains have an independent sig-
naling property, we designed constructs expressing either
Wnt3a CTD or NTD fragments (Figure 4A) and tested
their activities in vitro and in vivo. We found that con-
structs expressing Wnt3a subdomains did not activate
the Wnt reporter in cultured cells, neither alone nor
in combination (Figure 4B). When these single domain
constructs were co-transfected with full-length Wnt3a,
they both showed a moderate inhibition of the Wnt re-
porter activity. This is likely a result of competition for re-
ceptor binding, with the CTD having a stronger inhibitory
effect than the NTD. Combining both Wnt3a domains in
a triple co-transfection experiment with full-length Wnt3a
resulted only in a minor additive effect (Figure 4B). To
exclude the possibility that the loss of Wnt3a signaling
activity resulted from abnormal cellular synthesis or secre-
tion of the Wnt domain fragments, the Wnt3a NTD and
Wnt3a CTD were expressed as His-tagged fusion proteins
in HEK293T cells. We found that both Wnt3a domains
could be detected in the supernatants of transfected cells,
indicating there is sufficient structural integrity of the Wnt3a
domains for passing the cellular protein folding control of
the secretory pathway (Additional file 2: Figure S2).
To test our findings in vivo, we injected capped mRNAs
encoding for either mouse Wnt3a NTD or Wnt3a CTD
into Xenopus embryos. In comparison to the uninjected
controls (Figure 4C), mouse Wnt3a very effectively induced
secondary axes upon injection of 3 pg mRNA (Figure 4D),
while the separate Wnt3a domains did not show a compar-
able effect, even at a tenfold or 100-fold excess (Figure 4E,F,
Additional file 3: Table S1). Consistently, a combined in-
jection of equimolar mRNAs encoding for the two Wnt3a
domains also did not induce in vivo activity (Figure 4G),
indicating that the individual Wnt3a domains are not
able to activate Fz receptor signaling effectively in an
independent manner.
Physiological relevance of Wnt3a point mutations
To determine whether the above described Wnt3a
point mutations have any effect on the Wnt3a function
in vivo, we evaluated the activity of Wnt3a mutants that
were found to be critical in vitro by their expression in
the zebrafish embryo. Ectopic expression of Wnt an-
tagonists can promote head formation, whereas ectopic
activation of Wnt signaling during gastrulation blocks
head formation [16]. Furthermore, it was previously
shown that overexpression of zebrafish Wnt3 can ac-
tivate the canonical Wnt pathway within the zebrafish
embryo [17].
Figure 4 In vitro and in vivo activity of Wnt3a NTD and CTD
constructs. (A) Schematic representation of applied mouse Wnt3a
NTD and CTD constructs. (B) Wnt reporter assay in HEK293T
showing the effect of the Wnt3a NTD and CTD on signaling activity.
Experiments were carried out in triplicate. Error bars depict standard
deviation. Statistical significance in relative luciferase activity levels
compared to wild-type Wnt3a levels as indicated: *P< 0.05, **P < 0.01,
***P < 0.001 and n.s. as not significant according to Student’s t-test.
(C-G) Xenopus embryos at 4-cell stage were injected into the
ventral-marginal-zone with 3pg mRNA encoding wild type Wnt3a
(D), NTD (E), CTD (F) or NTD + CTD (G).
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Our in vivo studies revealed that injection of 3 pg
mouse Wnt3a capped mRNA per embryo causes a very
specific and robust effect on specifying the balance of
anterior-posterior cell fates along the neural axis in the
zebrafish, resulting in severe posteriorization of the anter-
ior nervous system (Figure 5A,B). Using optical section-
ing, we found that 2 pg of Wnt3a mRNA per embryo
leads to loss of the eye field, forebrain and partially also
midbrain structures (Figure 5B,C). These abnormalities
were specific to the cranial part of the embryos, whereas
the posterior part of the embryos showed no gross abnor-
malities. Injection of higher amounts of Wnt3a mRNA
led to severe abnormalities during gastrulation (Additional
file 4: Figure S3A,B), which were specific to high Wnt3a
expression levels only.
If our point mutations in mouse Wnt3a were deleteri-
ous for their activity in vitro, then similar levels of the
Wnt3a mutants would be expected to have no effect on
Figure 5 Expression of mouse Wnt3a mutants in zebrafish embryos. (A) Lateral view of zebrafish embryos, 1.5 days post fertilization (dpf),
upon injection of capped mRNA encoding wild-type and mutant mouse Wnt3a capped mRNAs. Note lack of forebrain, eye field and midbrain
structures in lateral view. (B) Posteriorizing effect of Wnt3a overexpression on zebrafish development as analyzed at 1.5 dpf. Pictures are single
optical sections either of lateral (upper panel) or medial (lower panel) sagittal sections, with staining for F-actin marking cell outlines and thereby
general nervous system morphology. The weaker phenotype with loss of retina and forebrain, though remnants of midbrain structures might be
present, is termed phenotype type I. The stronger phenotype (lacking the forebrain, retina, lens and midbrain) is phenotype type II. (C) Penetrance
of the dorsalized phenotype in zebrafish embryogenesis on wild-type and mutant mouse Wnt3a expression, quantified as a percentage. Type I
(weaker) and type II (stronger) respond to the phenotypes shown in Figure 5B. Total number of embryos (n) from three independent experiments:
non-injected: 403, EF1a: 76, wild-type mouse Wnt3a: 224, S209A: 113, G210R: 96, F331A: 79, W333A: 54, C335A: 91, V337R: 139, V60R: 86, E68A: 64,
A96R: 124, F169A: 82, E68A/F169A: 88 and F331A/W333A: 82. In all panels, anterior is to the left and dorsal is up. Eyes are outlined with dashed
pink lines. fb, forebrain; hb, hindbrain; l, lens; mb, midbrain; ov, otic vesicle; r, retina; WT, wild type; mhb, midbrain-hindbrain boundary.
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anterior-posterior neural axis establishment. We injected
a set of Wnt3a mutant capped mRNAs at 2 pg per em-
bryo and quantified the effects on embryo development
at 1.5 days post fertilization (dpf). As with the wild-type
mouse Wnt3a, the mutants F331A, W333A, C335A, V60R,
E68A, A96R and F169A (sites 2 and 3) led to severe defects
in the anterior-most neural system. They were character-
ized by the lack of a telencephalon and eye field structures
and occasionally also led to diminished mesencephalic
structures, compared to the non-injected or the EF1α
control embryos (Figure 5A). Interestingly, for the A96R
mutant, the effects were most severe among all expressed
constructs: very frequently the complete cranial part of
the embryonic axis was missing. In 24.8% of G210R-
expressing embryos, the eyes were either not present or
were significantly smaller. We were very intrigued by the
finding that when the V337R mutant was expressed,
81.3% of the injected embryos were normal and not distin-
guishable from the controls. Interestingly, of all injected
constructs carrying a single mutation in Wnt3a, only for
embryos injected with S209A isoform mRNA (94.7%) was
there no effect, either on the formation of the forebrain/
midbrain or on the eye field, suggesting the S209A muta-
tion is deleterious for the in vivo function of Wnt3a.
Double mutants, E68A/F169A (site 3) and F331A/W333A
(site 1), did not show any reversal of the phenotype and
their effects were not significantly different from the single
mutants at the gross morphological level. To ensure that
the tested mutants were expressed at similar levels in the
embryos, we designed in parallel His-tagged versions and
monitored Wnt3a protein levels in embryo lysates after
mRNA injection by Western blot analysis using an anti-
His antibody. As shown in Additional file 4: Figure S3C,
the Wnt3a mutants were all well expressed and the pro-
tein levels were comparable among the Wnt3a mutants,
with the exception of S209, which showed a reduced ex-
pression level of about 30% (Additional file 1: Figure S1).
Altogether, these results reveal that the mutations in
the F331, W333, C335, V60, E68, A96 and F169 residues
(sites 2 and 3) do not significantly impair Wnt3a in vivo
signaling in this context. As for the tests with cultured
HEK293T cells, the S209A mutant completely lost activ-
ity during zebrafish embryogenesis.
Interestingly, in this analysis we identified the V337R
mutation at site 2 as the most essential residue required
for signaling. We, therefore, analyzed this site in more
detail by performing a series of point mutations, in
which different amino acid side chains were tested for
their influence on signaling at this position. As shown in
Figure 6, an alanine substitution did not attenuate signal-
ing activity both in vitro and in vivo, whereas the slightly
more spacious isoleucine residue diminished activity quite
significantly in the zebrafish embryo (Figure 6C,D). Resi-
dues with more bulky side chains, such as tyrosine and
tryptophan, completely blocked Wnt3a biological activity
in both assays. Aspartic acid had a more dramatic effect in
the reporter assay than in the zebrafish embryo, indicating
a partial tolerance for this substitution in vivo. A possible
explanation for the spatial restrictions of this sensitive
Wnt3a binding site is provided by our model of the
V337W substitution in Figure 6B. In summary, the V337R
substitution stands out by abolishing signaling without
changing binding activity and thus could serve as a new
experimental tool that would enable manipulations of
reduced signaling by competing for receptor engagement.
Soluble Fz8-CRD protein influences Wnt3a signaling in a
biphasic manner
As our results of the site 2 mutations strongly suggested
an independent Fz binding site in the Wnt3a CTD, we
hypothesized that receptor engagement of the membrane-
associated Wnt is a two-step process, in which the initial
interaction with the Wnt3a CTD facilitates membrane
detachment of the lipid-modified NTD. Soluble CRD
proteins might, therefore, be able to augment Wnt signal-
ing by increasing the local concentration of membrane-
detached Wnt ligands. We tested this hypothesis by
performing a Wnt reporter assay with wild-type Wnt3a
in the presence of the Fz8-CRD-Fc protein at increasing
concentrations (Figure 7A). Moreover, soluble Fz8-CRD
protein applied at micromolar concentrations inhibited
Wnt signaling. In contrast, CRD concentrations that were
in the range or slightly above the Wnt3a concentration
in the cell supernatant (approximately 25 nM, Additional
file 5: Figure S4) increased luciferase activity threefold
compared to Wnt3a alone. To exclude cross-linking effects
by the Fz-CRD dimer in the applied Fc fusion construct, we
performed a control experiment using a monomeric Fz8-
CRD-His protein, which showed a similar biphasic effect
on Wnt3a activity (Additional file 6: Figure S5). Autocrine
signaling assays, such as the one applied in this experi-
ment, do not distinguish between secreted and cell-surface-
attached Wnt ligands. To confirm that the observed effect
was due to a higher amount of soluble Wnt3a ligands,
we incubated transfected HEK293T cells with different
amounts of Fz8-CRD-Fc protein and monitored Wnt3a
protein levels in the cell supernatants by Western blotting
(Figure 7B). The amount of soluble Wnt3a protein was, to a
large extent, correlated with the applied Fz8-CRD concen-
tration, while the supernatant levels of the non-binding
Wnt3a mutant W333A were not altered by the addition of
Fz8-CRD (Figure 7B, Additional file 1: Figure S1).
To provide further evidence that the observed increase
in Wnt signaling activity by the Fz8-CRD protein was due
to a higher mobility of the Wnt ligand, we performed a
double luciferase chamber assay, in which the Wnt3a
transfected cells were separated from the responder cells
by a porous membrane (Figure 7C, inset). The Fz8-CRD-
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Fc protein was applied at increasing concentrations to the
Wnt3a-producing cells. As shown in Figure 7C, we found
that the luciferase activity of the responder cells was mod-
ulated by the soluble CRD protein in a comparable manner
as in Figure 7A, suggesting that the increase of sig-
naling activity at nearly equimolar concentrations of
mouse Wnt3a and Fz8-CRD is independent of the direct
cell–cell contacts and autocrine signaling.
In conclusion, Wnt3a signaling activity was modulated
by the presence of soluble CRD protein, positively with
increased solubility at low CRD concentrations and
negatively at high CRD concentrations.
Discussion
Here, we present an in vitro and in vivo characterization
of the Wnt3a-Fz8 binding interface. We systematically
Figure 6 Influence of different V337 mutations on Wnt activity in vitro and in vivo. (A) Wnt reporter assay showing the influence of
different amino acid side chains at position V337 on the signaling activity of Wnt3a. Position V337 is highly sensitive towards bulky side chains as
illustrated in (B), which is an interaction model for the V337W mutant compared to the wild type. (C) Posteriorizing effect and (D) penetrance of
the dorsalized phenotype in zebrafish embryogenesis upon expression of wild-type mouse Wnt3a and diverse V337 mutants. Experiments were
carried out in triplicate. Error bars depict standard deviation. Statistical significance in relative luciferase activity levels compared to the wild-type
Wnt3a levels in (A) as indicated: *P < 0.05, **P < 0.01, ***P < 0.001 and n.s. as not significant according to Student’s t-test. wt, wild type.
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introduced a set of mutations in the Wnt3a sequence,
which were directed by a model of the mouse Wnt3a-
Fz8-CRD complex structure on the basis of the recently
published X-ray structure [9] (Figure 1A). Table 1 sum-
marizes the results obtained from the Wnt3a mutants
designed in this study.
Figure 7 Modulation of Wnt signaling by soluble Fz8-CRD-Fc.
(A) Wnt reporter assay showing the influence of purified mFz8-CRD-Fc
on Wnt signaling in a dose-dependent manner. (B) Immunoblot
depicting the influence of recombinant Fz8-CRD-Fc on the concentration
of soluble Wnt3a protein in the cell supernatant. The non-binding Wnt3a
mutant W333A was used as a control. For all conditions, cells were
seeded at equal cell density. (C) Double luciferase chamber assay using
CMV-β-galactosidase and Super TOPFlash reporter in HEK293 cells. The
Fz8-CRD-Fc protein was applied at increasing concentrations to the
Wnt-producing cells. Luciferase activity was monitored in Wnt3a
responder cells. Inset shows the set-up of the chamber assay. Experiments
were carried out in triplicate. Error bars depict standard deviation.
Statistical significance in relative luciferase activity levels compared to
the wild-type Wnt3a levels (A, C) as indicated: *P< 0.05, **P < 0.01,
***P < 0.001 and n.s. as not significant according to Student’s t-test.
CRD, cysteine-rich domain; WB, Western blot.
Table 1 Activity of Wnt3a mutants
Wnt3a mutants Wnt reporter
assay
Fz8
binding
Zebrafish
embryo
wt Wnt3a + + + + Abnormal
Site 1
K204A - nd nd
L208A - nd nd
S209A - - - - - 94% normal
G210R - - - - - 75% normal
W218A - nd nd
Site 2
F331A - - + + Same as wt
W333A - - + Same as wt
C335A - - - + Same as wt
Y336A + + nd nd
V337A + + nd Same as wt
V337D - - - nd 50% normal
V337I - nd 70% normal
V337R - - - + + 92% normal
V337Y - - - nd 92% normal
V337W - - - nd 94% normal
Pseudo site 3
I45R + + + nd nd
Y59A + + + nd nd
V60R - - + Same as wt
M63A + + + nd nd
P64A + + + nd nd
A67R + + + nd nd
E68A - - + nd
S92A + + + nd nd
N93A + + + nd nd
A96R + + + + + Same as wt
F169A - - - - Same as wt
R173A + + + nd nd
N175A - nd nd
Effect of Wnt3a mutants tested in TCF/Wnt-reporter, Fz8-CRD binding and
zebrafish embryo assays. For the Wnt reporter assay, + +, + + +, -, - - and - - -
represent, high (wild type), higher than wild type, lower than wild type, very
low and no signaling activity. For Fz8-CRD binding, + +, + and - - represent
full, low and no binding. For the zebrafish embryo assay, wt Wnt3a showed an
abnormally dorsalized phenotype, including defects in the formation of the
anterior-most neural system.
nd, not determined; wt wild type.
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When we mutated residues in mouse Wnt3a respon-
sible for the site 1 interaction (Figure 2), the Ser209 mu-
tation abolished signaling activity in the Wnt reporter
assay completely, due to its function as a lipid attach-
ment site. The importance of the lipid modification for
Wnt signaling has been repeatedly reported [4,18,19].
Interestingly, the Ser209 mutation also led to a complete
loss of binding to soluble Fz8-CRD (Figure 3A). In con-
cert with this, we found Ser209 to be crucial for Wnt3a
activity in injected zebrafish embryos in vivo. Based
on these data and on our analysis of isolated Wnt3a
domains, we conclude that the presence of both sites, 1
and 2, is essential for full binding and activity of Wnt3a.
Also, LRP binding sites in the linker between sites 1 and
2 might be sensitive to lacking conformational restrictions
imposed on this region by the simultaneous binding of
both sites to the Fz receptor [14]. Alternatively, the lack of
lipid modification could induce protein aggregate forma-
tion, precluding site 2 accessibility. Our finding that the
G210R mutation also leads to a complete loss of both
binding and signaling activity, although still partially active
in the embryos, suggests that it might be essential for the
lipid attachment as well. A potentially impaired binding
to Porcupine might explain such an effect. This hypoth-
esis is further supported by our finding that both G210R
and S209A show reduced binding to Blue Sepharose
(Figure 3B). Alternatively, a distortion of the thumb
loop interaction with Fz through the introduction of
a more spacious side chain could also lead to a largely
dysfunctional ligand through impaired site 1 interaction.
Likewise, a G210A mutation behaved like wild-type Wnt3a
in the Wnt reporter assay (data not shown). The G210
position is conserved in all Wnt ligands with the exception
of medaka and zebrafish Wnt8-like, where it is substituted
for glutamic acid [20]. Considering our findings, this
substitution is assumed to result in a Wnt ligand with
attenuated activity, which may have a distinct developmen-
tal function. Other conserved site 1 residues that were re-
ported to contribute secondarily to Fz interaction (K204A,
L208A and W218A) in XenopusWnt8 [9] showed a moder-
ate reduction in signaling activity for mouse Wnt3a,
both as single mutants and in combination (K204A/
L208A) (Figure 2A,G).
As predicted by the structural data, site 2 mutations
had a more significant effect on signaling in the Wnt re-
porter assay (Figure 2C). In particular, mutations in resi-
dues F331, W333, C335 and V337 that engage in van
der Waals interactions at the tip of the Wnt index finger
in the complex structure showed a significant loss of
ligand activity when mutated to alanine. C335, which
showed the strongest effect, forms a disulfide bond with
the adjacent Cys334, inducing a tight turn of the protein
backbone. We therefore presume that its mutation has an
additional impact on the overall structure of the binding
loop. When tested in the physiological context of zebrafish
embryogenesis, F331A, W333A and C335A mutations in
Wnt3a showed only mild deviations from the wild-type
Wnt3a, retaining most of their signaling capacity, which
might be due to compensatory effects by a different recep-
tor context and responsiveness of the tissue. This is also
supported by the fact that the Wnt3a E68 position, for
which an alanine mutation in the Wnt reporter assay
resulted in impaired signaling, is occupied by valine in the
Xenopus sequence. Small affinity differences between
wild-type Wnt3a and its mutants that seem to be relevant
in the cell culture luciferase assay were not detectable in
the binding assay or the embryo. The fact that the W333A
mutant, which shows both impaired signaling in a cell cul-
ture and significant loss of binding, still retains full activity
in the zebrafish embryo, might also point to different ex-
pression levels of Wnt signaling components in the two
systems. In particular, signal amplifiers, such as the LRP6-
axin complex [21], might contribute to the differences be-
tween the in vitro and in vivo results that we observed.
In addition, previous reports have shown that in the
absence of direct Wnt-CRD binding, the Wnt signal can
still be transduced [22,23]. Thus, Wnt ligands could main-
tain residual activity without CRD interaction, which
might be sufficient for a physiological response in vivo,
although below the detection threshold of an in vitro Wnt
reporter assay.
The V337R substitution, which had the most severe ef-
fect on signaling in both settings, most probably induces
a structural distortion of the binding loop due to sterical
hindrance. This is evidenced by the fact that an alanine
substitution did not alter signaling activity while an iso-
leucine substitution showed a significant impairment
in vivo (Figure 6C,D). Interestingly, the V337R mutation
did not significantly inhibit binding to Fz-CRD in solu-
tion (Figure 3A). This site can therefore be considered
as primarily important for signaling without contributing
to binding. Despite a very recent report on a naturally
occurring Wnt1 mutation of valine to phenylalanine at
position V337 (V335), causing osteogenesis imperfecta
through impaired Wnt signaling [24], the identification
of the residue V377 as being essential for Wnt3a activity
during zebrafish embryogenesis is novel. We conclude
that the insertion of W333 into the hydrophobic pocket
of the Fz receptor, as a critical binding event in the Wnt
CTD, might well be independent of the signaling compe-
tence of the ligand-receptor complex. The V337 position
is highly conserved in canonical and non-canonical
Wnts throughout the metazoan kingdom, underscoring
its essential role in receptor interaction and signaling.
Among site 3 mutants that abolished signaling, F169A
showed the most pronounced loss of binding. Interest-
ingly, position F169 in Wnt ligands is highly conserved,
and the interacting site in Fz CRDs and sFRPS is either
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phenylalanine or tyrosine, thus suggesting stacking inter-
actions of the aromatic residues. As F-Y and F-T pairs
exhibit different binding energies [25], this interaction
might be relevant for ligand-receptor specificity.
The lipid modification of Wnts [4] most probably acts as
a membrane anchor, bringing the CTD into a membrane-
distal position. We propose that the first contact with the
Fz-CRD and other CRD related proteins might be realized
via site 2, which in the second step facilitates membrane
detachment and a switch of the lipid chain into the site 1
binding pocket (Figure 8A). Soluble CRD-related proteins
should therefore effectively increase the amount of cell-
detached Wnt ligands. Furthermore, this results in an in-
creased spatial signaling range of Wnts by sFRPs in vivo
[26]. Our data on the modulatory activity of the Fz8-CRD-
Fc protein on Wnt signaling clearly support such a mech-
anism. In particular, by using a Wnt reporter assay with
separated chambers for Wnt-producing and -responding
cells, we were able to demonstrate that soluble CRD
proteins are able to promote Wnt signaling by facilitating
increased ligand mobility (Figure 7C).
The biphasic modulation of Wnt signaling that we ob-
served has also been described for sFRP-1 and is thought
to be caused by two separate binding sites for Wnt with
different affinities [27]. Our unexpected results obtained
for the majority of site 3 mutants (Figure 2F) might sug-
gest an alternative explanation. As this site was reported
to be possibly involved in higher-order Wnt-CRD com-
plexes, the increase in Wnt activity in Wnt3a mutant
proteins might indicate that oligomerization leads to a
depletion of active Wnt ligands. As Wnt-CRD complexes
at high concentration are more inclined to form aggre-
gates, the observed biphasic activity of the soluble CRD
protein might be caused by a shift in complex stoichiom-
etry (Figure 8B). This is also in line with the recent observa-
tions for a secreted splice variant of the Xenopus Frizzled-4
receptor [28]. Mutants that inhibit this process would ac-
cordingly increase the concentration of active Wnt-CRD
complexes, which facilitate efficient receptor engagement.
The severe effect of the A96R mutation in the zebrafish
embryo, together with its pronounced activity in the Wnt
reporter assay in cultured cells, both support such a
model. Moreover, this study identifies the A96R Wnt mu-
tant isoform as a possible new tool, relevant for the wider
field and representing a hyperactive Wnt ligand.
Conclusions
In summary, our analysis provides novel important insights
into structure function relationships of the Wnt-Fz inter-
action and its modulation by soluble CRD-related proteins.
The dissection of Wnt3a residues into sites essential for
binding and for signaling will clearly suggest new ap-
proaches for tackling the problem of ligand-receptor spe-
cificity in the Wnt field. In particular, our analysis of site 3
Figure 8 Model for Wnt-CRD complex formation. (A) Sequential binding of membrane-associated Wnt ligands to CRDs. The first binding step
is realized between the membrane-distal Wnt CTD and Fz-CRD or other CRD-related proteins via a site 2 interaction. This facilitates membrane
detachment of the Wnt NTD and a switch of the lipid chain into the site 1 binding pocket. (B) Biphasic modulation of Wnt activity by CRD proteins.
At low concentrations of CRD proteins, active Wnt-CRD complexes are formed by Wnt mobilization and transfer to Fz receptors. At high CRD
concentrations, oligomerization is induced via a site 3 interaction, leading to trapping of Wnt ligands in inactive Wnt-CRD aggregates.
CRD, cysteine-rich domain; CTD, C-terminal domain; NTD, N-terminal domain.
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residues, which likely induce CRD homo- or heterodi-
mers, contributes to a general understanding of different
signaling strategies in the context of different receptors
and soluble CRD-related factors.
Methods
Molecular biology
Mouse Wnt3a coding sequences were PCR amplified and
cloned into a pCS2+ expression vector using BamHI and
XhoI restriction sites. All point mutations were introduced
into full-length Wnt3a using PCR. All DNA fragments de-
rived from PCR were automatically sequenced to confirm
the presence of the desired mutation and to rule out spuri-
ous mutations. The NTD (1 to 276) and CTD (277 to 352)
of mouse Wnt3a were cloned into pCS2+ using the same
restriction sites as above. To generate a C-terminal His-
tagged version of mouse NTD and CTD, a histidine tag
was introduced by PCR amplification and cloned into the
pCS2 vector. To produce the Fz8-CRD-Fc fusion protein,
the CRD (i.e., the 135-amino-acid region extending from
the first to the tenth conserved CRD cysteine) was inserted
between EcoRI and BglII in the pFUSE-hIgG3*01-FC2 vector
(InvivoGen, San Diego, CA, USA), which contains an IL-2
signal sequence and a Cytomegalovirus immediate-early gene
1 enhancer and promoter, followed upstream by the hinge
region of a human IgG heavy chain.
Cell culture, DNA transfection and cell lysis
HEK293T cells and mouse L cells were routinely main-
tained in Dulbecco’s modified Eagle’s medium (Invitrogen,
Waltham, MA, USA) containing 10% fetal bovine serum
(FBS) (PAA, Freiburg, Germany) and 1% penicillin/
streptomycin in 5% CO2 at 37°C. Cells were split one day
prior to transient transfection and grown to 60 to 70%
confluence. HEK293T cells were transfected using jet-
PRIME™ (Peqlab, Erlangen, Germany) reagent (Polyplus
Transfection, USA) according to the manufacturer’s
protocol. To detect Wnt3a proteins in cell lysates,
HEK293T cells were transfected with wild-type Wnt3a or
its mutant isoforms. The cells were harvested after 48 hr
of transfection, washed with ice-cold 1× PBS and dis-
rupted in lysis buffer (20 mM Tris (pH 7.5), 150 mM
NaCl, 1% NP-40, 10 mM ethylenediaminetetraacetic acid
(EDTA) protease inhibitor cocktail complete (Roche Diag-
nostics GmbH, Mannheim, Germany). The resulting
supernatant was transferred to a fresh tube. Proteins were
analyzed by Western blot using anti-Wnt3a antibody. For
loading control, the membranes were probed with anti-α-
tubulin.
Antibodies
Rabbit polyclonal antibodies against mouse Wnt3a were
obtained from Abcam (Camebridge, UK) [29]. Penta-His
antibodies were obtained from Qiagen (Hilden, Germany).
Mouse monoclonal antibodies against α-tubulin and
goat anti-human IgG (Fc specific) antibodies were ob-
tained from Sigma (St. Louis, MD, USA). Goat anti-
rabbit and rabbit anti-mouse secondary antibodies were
obtained from Jackson ImmunoResearch (Bar Harbor,
ME, USA).
Dual luciferase assay
HEK293T cells were seeded in 384-well plates 24 hr
prior to transfection. Cells were transfected with the re-
porter construct TCF-firefly (10 ng) [30], actin-Renilla
(10 ng) and Wnt3a (5 ng) or mutant isoforms, and bal-
anced with an empty expression vector (pRL-CMV)
using TransIT (Mirus Bio LLC, Madison, WI, USA)
according to the manufacturer’s protocol. The activity of
the firefly luciferase and Renilla luciferase was measured
using the dual luciferase assay kit (Promega, Madison,
WI, USA) and detected using a Mithras LB940 Multi-
mode Microplate Reader Luminometer (Berthold Tech-
nologies, Bad Wildbad, Germany). The activity of the
Renilla luciferase was measured as an internal control of
transfection efficiency. The activity of the Wnt-induced
Wnt reporter is depicted as the ratio of the activity of the
firefly to Renilla luciferase. All assays were performed in
triplicate and repeated in three independent experiments.
Production of mouse Wnt3a and mutant isoforms in
HEK293T cells
To collect a conditioned medium of wild-type mouse
Wnt3a and the indicated mutants, HEK293T cells were
transiently transfected with the corresponding cDNAs
under control of a Cytomegalovirus immediate early gene
enhancer and promoter. For protein expression, cells were
incubated at 37°C for 48 hr in DMEM (Invitrogen,
Waltham, MA, USA) containing 10% FBS and penicillin/
streptomycin. The conditioned media were harvested,
centrifuged at 2,000 g for 10 min, and directly used or
stored in aliquots at −80°C. The control medium was pre-
pared from untransfected HEK293T cells following the
same protocol. For the solution binding assay, the condi-
tioned media containing wild-type Wnt3a or mutant iso-
forms were produced in a low serum (3% FBS) condition
and adjusted to give equal Wnt3a protein levels by quanti-
fying Western blot bands as described below. To detect
the secretion levels of wild-type Wnt3a and mutant iso-
forms, equal amounts of conditioned medium were re-
solved on 12% SDS-PAGE and analyzed by Western blot
using anti-Wnt3a antibody.
To produce the NTD-His and CTD-His conditioned
medium, HEK293T cells were transiently transfected with
10 μg of the relevant plasmid. One day after transfection,
cells were transferred to advanced low serum DMEM/F-12
(GIBCO, Invitrogen Corporation, Waltham, MA, USA),
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and secreted proteins were harvested after an additional 48
hr. Proteins were purified by incubating the condi-
tioned medium with Ni-NTA agarose beads (Qiagen,
Hilden, Germany) for 1 hr at 4°C. Bound proteins were
solubilized with elution buffer (300 mM imidazole, 250
mM NaCl, 1× PBS). Purified proteins were resolved on
SDS-PAGE and analyzed by Western blot using anti-His
antibodies.
Production of recombinant Fz8-CRD proteins
The mouse Fz8-CRD-Fc and Fc were produced in
HEK293T cells that were transiently transfected by
using jetPRIME™ reagent (Polyplus Transfection,
USA). One day after transfection, cells were trans-
ferred to advanced low serum DMEM/F-12 (GIBCO,
Invitrogen corporation), and secreted protein was
harvested after an additional 48 hr. The control condi-
tioned medium was obtained from untransfected
HEK293T cells. To purify the Fz8-CRD-Fc and Fc, the
conditioned medium was incubated with Protein G
Agarose (Roche Diagnostics GmbH) for 3 hr at 4°C, and
washed three times with washing buffer (10 mM Tris-Cl
(pH 7.8), 0.2 mM EDTA, 250 mM NaCl, 0.1% Tween).
Proteins were eluted in low pH elution buffer (0.1 M
glycine-HCl (pH 2.5), 0.1% Tween) and immediately
neutralized with 1 M Tris–HCl (pH 9.0). Purified
protein was resolved on SDS-PAGE and analyzed by
Western blot and Coomassie blue staining.
Mouse Fz8-CRD-His was cloned into the pCEP-PU vec-
tor (Invitrogen). To produce the Fz8-CRD-His protein,
HEK293T cells were transiently transfected with 10 μg of
plasmid. The conditioned medium was harvested after 48
hr of transfection. Fz8-CRD-his was further purified by
incubating 50 ml of conditioned medium with 200 μl
Ni-NTA agarose beads (Qiagen) for 1 hr at 4°C. The
beads were washed three times with 1× PBS, 0.1% Tween.
Bound protein was eluted with elution buffer (300 mM
imidazole, 250 mM NaCl, 1× PBS (pH 7.5)).
Solution binding assay
First 12 μg recombinant mouse Fz8-CRD-Fc or Fc alone
as a negative control were pre-incubated with Protein G
Agarose (Roche Diagnostics GmbH) for 3 hr at 4°C, then
the beads were washed twice with 0.01% Triton X-100,
1× PBS, and twice with 1× PBS. The beads were then in-
cubated with 1 to 2 ml of Wnt3a conditioned medium
for 3 to 4 hr. The beads were separated by centrifugation
and washed four times with 0.01% Triton X-100, 1× PBS
buffer and boiled in 2× SDS sample buffer containing
beta-mercaptoethanol. The supernatants were analyzed
by Western blot analysis using anti-Wnt3a primary anti-
bodies. The membranes were further re-probed with
anti-human IgG antibodies.
Blue Sepharose pull-down of Wnt3a proteins from
conditioned medium
Wnt3a-conditioned medium (2 to 5 ml) was collected
from HEK293T cells transiently transfected with differ-
ent Wnt3a expression constructs. The Wnt3a protein
levels were adjusted according to the quantitative band
intensities after Western blotting with mouse ant-Wnt3a
antibodies. The conditioned medium was incubated with
30 μl Blue Sepharose beads (GE Healthcare Life Sciences,
Chalfont St. Giles, UK) on a rocking platform for 2 hr at
4°C. The beads were washed four times with washing buf-
fer (1× PBS, 0.1% Tween-20). A protein sample buffer
containing SDS and 150 mM DTT was added to the beads
and the mixture samples were heated at 95°C for 5 min.
Proteins were resolved on 12% SDS-PAGE and analyzed
by Western blot using anti-Wnt3a antibodies.
Modulation of Wnt3a activity and solubility by soluble
Fz8-CRD protein
To investigate the effect of recombinant Fz8-CRD-Fc on
Wnt activity, HEK293T cells were transfected with re-
porter construct TCF-firefly (10 ng) [30], actin-Renilla
(10 ng) and Wnt3a (5 ng). After 24 hr of transfection,
the indicated amount of Fz8-CRD-Fc was added to the
cells and the relative luciferase activity was measured
after another 24 hr .
To investigate the effect of recombinant Fz8-CRD pro-
tein on Wnt solubility, HEK293T cells were transfected
with wild-type or W333A mutant Wnt3a plasmid in 24-
well plates and cultivated in 500 μl DMEM medium sup-
plemented with 10% FCS. After 24 hr, the indicated
amount of recombinant Fz8-CRD-Fc was added to the
Wnt3a-producing cells, which were further incubated
for 16 to 20 hr. The supernatant containing wild-type or
mutant Wnt3a protein was analyzed by Western blot
using the anti-Wnt3a antibody.
For the dual luciferase chamber assay, HEK293T cells
were seeded on thinCerts TC chambers with a pore size
of 8.0 μm (Greiner, Frickenhausen, Germany), trans-
fected with 0.25 μg CMV-β-galactosidase and 0.4 μg
Super TOPFlash by Ca++-phosphate precipitation and
cultivated in 1 ml DMEM supplemented with 10% FCS.
Then 40 hr before analysis, the inlets with the transfected
cells were transferred to mWnt3a-producing cells
(ATCC, Manassas, VA, USA: CRL-2647) seeded in 500
μl DMEM supplemented with 10% FCS in 12-well
plates. Then, 16 hr before analysis the indicated amount
of recombinant Fz-CRD protein was added to the Wnt-
producing cells.
mRNA microinjections in frog (Xenopus) and zebrafish
(Danio rerio) embryos
Xenopus eggs were obtained from females injected with
500 IU of human chorionic gonadotropin (Sigma-Aldrich,
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USA) and fertilized in vitro. Embryos were dejellied in 2%
cysteine hydrochloride (pH 8) and microinjected into 1×
MBS-H (88 mM NaCl, 1 mM KCl, 2.4 mM Na2HCO3,
0.82 mM MgSO4, 0.33 mM Na(NO3)2, 0.41 mM CaCl2, 10
mM HEPES pH 7.4, 10 μg/ml streptomycin sulfate, and
10 μg/ml penicillin). The embryos were cultured in 0.1×
MBS-H and staged according to Nieuwkoop [31]. Capped
mRNAs coding for wild-type mWnt3a, NTD and CTD
were synthesized from linearized pCS2+ plasmids using
the Message Machine Kit (Ambion, Grand Island, NY,
USA). Plasmids were linearized with NotI and transcribed
with SP6. Embryos for the axis-duplication assay were
injected at the ventral marginal zone with the indicated
amount of mRNAs and screened for axis-duplication after
48 hr with an Olympus (Hamburg, Germany) SZX12
stereomicroscope and a Soft Imaging System CC-12 digital
camera.
Zebrafish of the AB wild-type line were raised and
staged as described previously [32]. For zebrafish injec-
tion experiments, a series of 1.5, 3, 33, 100 and 300 pg
of wild-type mWnt3a mRNA was first injected and
dose-dependence evaluated. Since 3 pg of mWnt3a or
more caused very severe abnormalities at 1 dpf, there-
fore 2 pg of each mRNA was microinjected into one-
cell-stage embryos in experiments as shown in Figure 6.
Embryos were incubated in E3 medium (with additional
PTU treatment after 20 hr post fertilization) at 28°C and
examined at 1, 1.5 and 3 dpf. Zebrafish embryos were ei-
ther photographed live or fixed with 4% PFA and stained
with Alexa-488 conjugated Phalloidin (Molecular
Probes, Grand Island, NY, USA), mounted in 1% low
melting point agarose and imaged on an A1R (Nikon,
Tokyo, Japan) confocal microscope using a 40× LWD
water immersion objective.
To monitor expression levels of the mouse Wnt3a pro-
teins, 25 pg of the His-tagged wild-type mouse Wnt3a
capped mRNA or its mutant versions were injected into
zebrafish embryos at the one-cell stage. After 8 to 9 hr
(at the gastrula stage), 20 embryos were lysed in 100
μl SDS-PAGE sample buffer (100 mM Tris–HCl (pH
6.8), 20% glycerol (v/v), 4% SDS (w/v), 100 mM DTT)
and homogenized by passing through a fine needle. The
embryo lysate was further centrifuged at 12,000g for 10
min at 4°C to remove debris. The supernatants were
transferred to a new tube and the proteins were separated
on 12% SDS-PAGE and analyzed by Western blotting
using anti-His5 antibodies.
Western blot quantification
Chemiluminescence was detected with a photographic film
(Amersham Hyperfilm ECL, GE Healthcare, Chalfont St.
Giles, UK) in a Curix 60 processor (Agfa, Mortsel,
Belgium). Films of immunoblots were scanned into TIF
format using a CanoScan LiDE 35 (Canon, Tokyo, Japan)
and digital images were imported and quantified using
ImageJ software (National Institutes of Health, Berthesda,
MD, USA) following the method outlined in [33]. The
quantitative band intensities of Wnt3a mutant proteins
were normalized relative to the wild-type Wnt3a protein
band intensity.
Modeling of Wnt3a structure
We performed homology modeling based on the most re-
cently determined crystal structure of the XWnt8-Fz8-CRD
complex [9] (pdb-code: 4F0A). Both ligand and receptor
had homology scores of >75%. For the subsequent model-
ing steps, two criteria were important: the e-value as
returned by BLASTP against the PDB dataset and the 3D-
Jury score from metaserver, which is an approximation of
the number of Cα atoms within 3.5 Å from the PDB tem-
plate compared to the current theoretical model. Since
the secondary structure coverage of PDB corresponded to
the secondary structure elements predicted for Wnt3A by
PSIPRED [34], DSSP [35], STRIDE [36] and PROFSEC
(B. Rost, unpublished data), it seemed reasonable to try a
homology modeling protocol to the PDB from XWnt8-Fz8-
CRD as templates using alignment information provided
by metaserver. Modeller9v2’s [37] script for automated
model generation using homology modeling was run with
successive molecular dynamics simulated for annealing
refinement (refine.slow). Optimization was repeated four
times to get the first impression of the model. Finally, the
model was optimized with the variable target function
method (VTFM), which tries to minimize constraint
violations (e.g., torsion angles) with a maximum of 300
iterations.
Ethical approval
The zebrafish were maintained in the closed stocks at
the University of Heidelberg. Zebrafish husbandry were
performed according to local animal welfare standards
(Tierschutzgesetz 111, Abs. 1, Nr. 1, Haltungserlaubnis)
and in accordance with European Union animal welfare
guidelines.
Additional files
Additional file 1: Figure S1. Western Blot quantifications. Relative
intensities of western blot bands were quantified using ImageJ software.
(A-C) Quantification for cell supernatants of site 1, site 2, and site 3
mutants, respectively. (D) Quantification for His-tagged versions of
wild-type and mutant Wnt3a proteins in injected zebrafish embryo lysates.
(E) Quantification for Wnt3a protein in the supernatant of transfected
HEK293T cells incubated with increasing amounts of Fz8-CRD-Fc protein as
indicated. (F) Quantification for W333A Wnt3a protein in the supernatant of
transfected HEK293T cells incubated with increasing amounts of Fz8-CRD-Fc
protein as indicated.
Additional file 2: Figure S2. Secretion levels of His-tagged the Wnt3a
NTD and CTD. Equal amounts of conditioned medium containing Wnt3a
NTD and CTD protein were precipitated and analyzed by Western blot
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using anti-his antibodies. The calculated molecular masses are 31.4 kDa
for Wnt3a NTD and 11.6 kDa for the CTD, respectively. An unspecific
serum protein at about 17 kDa was co-precipitated in all samples,
including the vector control. The second band in the CTD lane at
about 15 kDa likely represents a different conformational state due to
partial disulfide bonding. CTD, C-terminal domain; NTD, N-terminal
domain; WB, Western blot.
Additional file 3: Table S1. The effect of Wnt3a NTD and CTD mRNAs
on secondary axis development in Xenopus embryos.
Additional file 4: Figure S3. Effect of ectopic mouse Wnt3a capped
mRNA injections on zebrafish embryonic development. (A) Pictures of
live embryos in lateral view. Anterior is to the left and posterior to the
top. Note the effect of 3 pg mouse Wnt3a mRNA injection on loss of eye
field and forebrain. Midbrain-hindbrain barrier (arrows) is still present.
Upon injection of 33 pg mouse Wnt3a mRNA or more, the embryos are
not able to gastrulate properly. (B) Quantification of the effect of full-length
wild-type mouse Wnt3a mRNA on zebrafish embryonic development.
Number of embryos analyzed for each condition: non-injected: n = 65, 3 pg:
n = 81, 33 pg: n = 82, 100 pg: n = 93 and 150 pg: n = 74. (C) Levels of ectopic
mouse Wnt3a protein expression in zebrafish embryos. The Western blot
was probed with anti-His5 antibodies. It shows the total levels of His-tagged
wild-type mouse Wnt3a and mutant proteins. The same membrane was
probed with anti-alpha tubulin as a loading control.
Additional file 5: Figure S4. Estimation of mouse Wnt3a concentration
in a conditioned medium of HEK293T cells. First 20 μl of conditioned
medium from HEK293T cells expressing wild-type mouse Wnt3a were
blotted together with increasing amounts of commercial recombinant
mouse Wnt3a using anti-Wnt3a antibody. The intensity of the Wnt3a
band in the conditioned medium was found to be between the intensities
of the 10 and 25 ng bands. WB, Western blot; CM, conditioned medium.
Additional file 6: Figure S5. Modulation of Wnt signaling by soluble
monomeric Fz8-CRD-His. The Wnt reporter assay shows the influence of
purified mFz8CRD-His on Wnt signaling in a dose-dependent manner.
The experiment was performed in four replicates. Bars represent standard
deviation of the mean. Statistical significance in relative luciferase activity
levels compared to the wild-type Wnt3a levels as indicated: *P < 0.05,
**P < 0.01, ***P < 0.001 and n.s. as not significant according to Student’s
t-test. CRD, cysteine-rich domain.
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